What is NVSEF's gross margin?

Novartis (NVSEF) has a gross margin of 74% and a net margin of 23%.

What is NVSEF's P/E ratio?

NVSEF's P/E ratio is 21.3 with ROE of 30%.

Where can I see NVSEF's full financials?

See Novartis (NVSEF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Novartis (NVSEF) Financials — Revenue, Earnings, Cash Flow

Also trades as: NOVN.SW (SIX) · $vol 405M · NVS (NYSE) · $vol 285M · NVS.TO (TSX) · $vol 0M

$134.20

-6.73 (-4.78%)

Weekly Expected Move ±9.8%

$108 $121 $134 $147 $160

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 43 · $255.1B mcap · 1.61B float · 0.0010% daily turnover · Short 8% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$55B

Revenue

-0.8% YoY

$13B

Net Income

-7.8% YoY

$16B

Free Cash Flow

-11.6% YoY

74.5%

Gross Margin

32.8%

Op. Margin

22.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE30.3%

ROA11.2%

ROIC16.6%

Valuation

P/E21.3

P/B6.4

EV/EBITDA14.8

Leverage

Debt/Equity1.18

Current Ratio0.86

Interest Cov.12.5x

Quality Scores

Piotroski F5/9

Altman Z3.53

Beneish M-2.52